4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-048561
President, R&D sold 4,900 shares at $25.46 ($124,754)
- President, R&D acquired 4,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-09-02 | Option exercise | +4,900 | $4.12 | $20,188 | 94,559 | D |
| Bergstrom Donald A President, R&D | 2022-09-02 | Sale | −4,900 | $25.46 | $124,754 | 89,659 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-09-02 | Option exercise · Stock Option (Right to Buy) | −4,900 | 134,456 | D | ||
| Open-market sales · 4,900 sh · avg $25.46 · $124,754 | |||||||
Loading xslF345X03/doc4.xml…